Patientfarmakokinetiske data indikerer at der ikke er set klinisk signifikante forskelle i caspofungins farmakokinetik hos patienter af europæisk, negroid, sydamerikansk og sydamerikansk/ indiansk afstamning.
Patient pharmacokinetic data indicated that no clinically significant differences in the pharmacokinetics of caspofungin were seen among Caucasians, Blacks, Hispanics, and Mestizos.